Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916341 · ClinicalTrials.gov registry record · NA
Smoking and Ventricular Repolarization
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03916341 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 110 participants.
The verdict
NCT03916341, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization.
Interventions
- OTHER control
- OTHER EC with nicotine
- OTHER EC without nicotine
- OTHER TC with nicotine (own brand)
- OTHER research TC with very low level nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2023-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03916341
The ClinicalTrials.gov registry entry for NCT03916341 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which control is the first listed.
NCT03916341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03916341 about?
NCT03916341 is a clinical study titled "Smoking and Ventricular Repolarization". Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization.
What is the current status of trial NCT03916341?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2019-10-01. Estimated completion is 2023-04-10.
What interventions are being tested in trial NCT03916341?
The interventions under investigation include: control (OTHER), EC with nicotine (OTHER), EC without nicotine (OTHER), TC with nicotine (own brand) (OTHER), research TC with very low level nicotine (OTHER).
Who is sponsoring clinical trial NCT03916341?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.